Cardiac sarcoma presenting with abdominal pain and mimicking myxoma on echocardiogram by Diab, MS et al.
Case Report
Cardiac sarcoma presenting with abdominal pain and
mimicking myxoma on echocardiogram
Mohammad S Diab1, Jeremy Smelt1, Nick Fletcher2 and Mazin Sarsam1
1Department of Cardiothoracic Surgery, St. George’s Hospital, London SW17 0QT, UK
2Department of Anaesthesia, St. George’s Hospital, London SW17 0QT, UK
Corresponding author: Mohammad S Diab. Email: diab.mohammed@gmail.com
Lesson
Cardiac sarcoma’s are highly aggressive tumours. Clear
resection margins autotransplant, followed by che-
motherapy, offers the best survival chance. Therefore,
frozen section should be preformed when there is ambi-
guity in diagnosis.
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Introduction
We present an unusual case of an AMI due to super-
ior mesenteric artery (SMA) embolus originating
from a left atrial sarcomatoid neoplasm mimicking
a myxoma on echocardiogram. Acute mesenteric
ischaemia (AMI) is associated with high mortality
and the usual culprits are emboli due to atrial ﬁbril-
lation or following low cardiac output state.
The patient underwent emergency embolectomy
and bowel resection followed by cardiac surgery.
Frozen section conﬁrmed an undiﬀerentiated sar-
coma. Frozen section is necessary to identify malig-
nant cardiac tumours and perform extensive tumour
resection to obtain clear margin which dictates
survival.
Case presentation
A previously ﬁt and well 45-year-old man attended
his local hospital with abdominal pain. He had raised
inﬂammatory markers and serum lactate. Abdominal
CT angiogram revealed a superior mesenteric artery
embolus and evidence of infarcted bowel.
The patient underwent a laparotomy, superior
mesenteric artery embolectomy and 30 cm of ischae-
mic jejunum was resected and a primary anastomosis
was formed. The histology showed ischaemic bowel
only. Transthoracic echocardiogram showed the
presence of a large left atrial mobile mass attached
via a pedicle, prolapsing through the mitral valve
from the left atrium at 3.4 cm in length (Figure 1.)
It was unclear whether this was a myxoma or a
thrombus. The patient’s ventricular function was
normal and a coronary angiogram was reported as
normal. He was transferred to a cardiac centre and
underwent median sternotomy and aortobicaval can-
nulation 17 days after his laparotomy. The heart was
arrested with anterograde and retrograde cardiople-
gia. The mass was found to be densely adherent to the
left atrial free wall through to the right pulmonary
veins and the superior vena cava, which was then
detached from the right atrium for access.
Ambiguity about the tumour’s nature made us send
a frozen section specimen which revealed sarcoma-
toid appearances. The mass was peeled oﬀ the anter-
ior mitral valve leaﬂet and excised with the invaded
structures. The sinoatrial node had to be sacriﬁced.
Bovine pericardium was used to reconstruct the left
and right atrium and right pulmonary veins
(Figure 2). On coming oﬀ, bypass mitral regurgita-
tion was observed via the transesophageal echo and
so the neo left atrium was reopened and a 32mm
Cosgrove-Edwards ring implanted. The patient had
an uncomplicated and short hospital stay. Histology
was consistent with mildly pleomorphic spindle shape
sarcoma supported by positive immunohistochemis-
try for SMA and the presence of MDM2 gene amp-
liﬁcation. Despite the extensive tumour resection and
chambers reconstruction, there was tumour margin
involvement. The patient remains well ﬁve months
later and is under the care of a sarcoma oncology
team.
Discussion
Primary cardiac tumours are rare (<0.04%), but
fatal.1 Malignant tumours constitute 25% of all pri-
mary cardiac tumours, of which sarcomas comprom-
ise >75%.1 Surgery achieves the optimal results for
treatment of localised sarcomas. Prognosis is depend-
ent on radical tumour resection.2 There is still no
clear deﬁned treatment guidelines for malignant
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cardiac tumours. There is no gender preference
noted, and presentation is usually in the fourth
decade of life.3 Three large series (reviewing 34, 21
and 95 cases respectively) showed that overall median
survival was 12–20 months.3–5 Moreover, they also
showed that survival was 6–10 months in R1 resec-
tion while that improved to 12–24 months in R0
resection. Surgical mortality was reported to be
high (8.3%), albeit acceptable.4
Due to the paucity of cases of this tumour, deﬁnite
pathological or radiological diagnostic characteristic
is challenging. Echocardiography detects cardiac
tumours with high sensitivity and speciﬁcity,2 but
only endocardial biopsy gives the deﬁnitive diagno-
sis.2 Usually, the rapidly progressive clinical course,
multiple tumour growths and non-septal attachment
of the tumour all suggest a malignant proﬁle of the
primary cardiac tumours. In our case, the tumour
was attached to the septum and at the same time
extending into the pulmonary veins. There was uncer-
tainty in diagnosis and a frozen section conﬁrmed the
diagnosis and immediate reconstructive surgery to
clear the tumour was performed.
As with any malignant tumour, we put the emphasis
on clear resection margin to provide the best disease-
free survival. In two isolated case reports of left atrial
sarcomas, the patients survived for 7 and 11 years.6,7
In both reports, the patients underwent a re-operation
for local recurrence. Unsurprisingly, case series have
shown that R0 resection can be achieved in only
38–42% of cases.3–5 Furthermore, emergency surgery
was performed for palliation or to prevent further
embolism that can lead to partial tumour resection.
Thus, local recurrence is certain. Therefore, chemother-
apy should be almost always administered. There has
been controversy about oﬀering heart transplant, and
inmany studies that showed no surgical advantage over
surgical resection chemotherapy.1,2 Also, there have
been ethical issues about oﬀering heart transplant to
patients with malignant cardiac tumours. There is no
speciﬁc guidance on chemotherapy regimens, but it
seems thatmultiple chemotherapies are better and guid-
ance should be aided by C-Kit sensitives.
To conclude, endocardial frozen section is neces-
sary when there is echocardiographic ambiguity
about the tumour nature. We recommend close
follow-up and chemotherapy in all cardiac sarcomas.
Primary (intimal) spindle shape sarcoma is very
aggressive and R0 resection is diﬃcult to achieve
and heart transplantation may be indicated when
Figure 1. Transesophageal echocardiogram demonstrating a wide base left atrial mass (arrow).
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metastatic workup is negative. A cardiac sarcoma
registry is required to obtain more solid management
guidelines.
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Figure 2. Intraoperative view. (a) Note that the tumour extends into and through the wall of the superior vena cava and the left
atrial dome; (b) Complete tumour removal by en bloc resection, including the right atrial anterior and lateral wall, left atrial dome,
and a large segment of the superior vena cava; (c) Repair of the left atrial dome; (d) Reconstruction of the right atrium and
superior vena cava with bovine pericardium.
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